Clinical trial
Open, Multicenter Observational Study of Paclitaxel Utilized in Mono- or Combination Therapy for the Treatment of Breast Cancer, Non-small Cell Lung Cancer and Ovarial Cancer.
NCT01668108 is registered in ClinicalTrials.gov with Onkovis GmbH as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Open, Multicenter Observational Study of Paclitaxel Utilized in Mono- or Combination Therapy for the Treatment of Breast Cancer, Non-small Cell Lung Cancer and Ovarial Cancer.
- Lead sponsor
- Onkovis GmbH
- Phase
- Observational
- Overall status
- Completed
- Start date
- August 31, 2012
- Completion date
- May 31, 2018
- Enrollment
- 770 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.